- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07945691
Imaging Follow-up After Stone Treatment
Imaging Follow-up of Patients With Urinary Stones: Ultrasound-Based Randomized Controlled Trial
Kidney stones are a common condition that can recur even after successful treatment. Regular imaging tests can help detect new stones, but frequent use of X-rays and CT scans can expose patients to unnecessary radiation. It is not yet clear how often patients should have imaging tests after treatment.
This study compares two schedules for monitoring patients who have undergone treatment for kidney stones and have no significant remaining stones. Participants are randomly assigned to one of two groups. One group has an ultrasound examination of the kidneys and urinary tract every 6 months, while the other group has the same examination every 12 months.
The study aims to determine whether more frequent ultrasound examinations can reduce unexpected episodes related to kidney stones, such as pain, bleeding in the urine, or urinary infections caused by blocked urine flow.
The researchers will also assess changes in kidney function, visits to the emergency department, the number of imaging tests performed, the development or growth of stones without symptoms, and the overall cost of imaging.
The study includes adults with a low or high risk of kidney stones recurrence and is conducted at Sismanoglio General Hospital in Athens, Greece.
The findings may help determine an appropriate schedule for monitoring patients after kidney stone treatment while reducing unnecessary tests, radiation exposure, and healthcare costs.
Panoramica dello studio
Stato
Intervento / Trattamento
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Lazaros Tzelves
- Numero di telefono: 00306944104974
- Email: lazarostzelves@gmail.com
Backup dei contatti dello studio
- Nome: Panagiotis Neofytou
- Numero di telefono: 00306996288898
- Email: neo.panagiotis@gmail.com
Luoghi di studio
-
-
Attica
-
Athens, Attica, Grecia, 15126
- 2nd Department of Urology, Sismanoglio General Hospital
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Adults aged 18 years or older, including both males and females.
- Patients with urolithiasis of any stone composition.
- Patients with stones at any anatomical location.
- Patients undergoing any definitive stone treatment procedure, including extracorporeal shock wave lithotripsy (SWL), ureteroscopy (URS), retrograde intrarenal surgery (RIRS), or percutaneous nephrolithotomy (PCNL).
- Patients classified as either low-risk or high-risk for stone recurrence according to European Association of Urology (EAU) criteria.
- Patients with no significant residual stone fragments following treatment, defined as the absence of residual fragments larger than 2 mm at 4-6 weeks after the procedure, assessed by radiography and ultrasound or low-dose computed tomography.
Exclusion Criteria:
- Refusal to participate in the study.
- Patients with anatomical abnormalities or a history of previous open surgery for stone disease.
- Patients with a solitary kidney or chronic kidney disease.
- Patients with occupations considered to be associated with a high risk of stone disease, such as pilots.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: 6-monthly ultrasound follow-up
|
kidney, ureter, bladder ultrasound every 6 months kidney, ureter, bladder ultrasound every 12 months |
|
Comparatore attivo: 12-monthly ultrasound follow-up
|
kidney, ureter, bladder ultrasound every 6 months kidney, ureter, bladder ultrasound every 12 months |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Incidence of Symptomatic Stone Episodes
Lasso di tempo: from randomization until the end of follow-up period, 1 year after intervention
|
Occurrence of symptomatic stone episodes during a one-year follow-up period, defined as any of the following: a new episode of renal colic or pain, hematuria not attributable to another cause, or urinary tract infection associated with obstruction caused by a newly formed stone. In patients with no visible residual stone fragments after treatment, the detection of any stone during follow-up will be considered recurrence. In patients with residual fragments smaller than 2 mm, detection of any fragment measuring 3 mm or larger will be considered recurrence. |
from randomization until the end of follow-up period, 1 year after intervention
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Estimated Glomerular Filtration Rate (eGFR)
Lasso di tempo: from randomization until the end of follow-up period, 1 year after intervention
|
Change in estimated glomerular filtration rate (eGFR) during the follow-up period, as an indicator of changes in kidney function. |
from randomization until the end of follow-up period, 1 year after intervention
|
|
Number of Emergency Department Visits
Lasso di tempo: from randomization until the end of follow-up period, 1 year after intervention
|
Number of visits to the emergency department during the follow-up period. |
from randomization until the end of follow-up period, 1 year after intervention
|
|
Number of Imaging Examinations Performed
Lasso di tempo: from randomization until the end of follow-up period, 1 year after intervention
|
Total number of imaging examinations performed during the follow-up period for the evaluation of urolithiasis, including plain radiographs, computed tomography scans, and ultrasound examinations. |
from randomization until the end of follow-up period, 1 year after intervention
|
|
Incidence of Asymptomatic Stone Growth
Lasso di tempo: from randomization until the end of follow-up period, 1 year after intervention
|
Number of patients who develop asymptomatic stone growth during the follow-up period, as detected by imaging examinations. |
from randomization until the end of follow-up period, 1 year after intervention
|
|
Total Cost of Imaging Examinations
Lasso di tempo: from randomization until the end of follow-up period, 1 year after intervention
|
Total cost of imaging examinations performed during the follow-up period for the evaluation and monitoring of urolithiasis. |
from randomization until the end of follow-up period, 1 year after intervention
|
Collaboratori e investigatori
Collaboratori
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 5949/21.01.2025
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .